MedPath

Suppression of vascular wall Healing after IMplantation of drug Eluting peripheral stent in Japanese patients with the Infra inguinal lesion: serial angioscopic observatio

Not Applicable
Recruiting
Conditions
arteriosclerosis obliterans
Registration Number
JPRN-UMIN000018314
Lead Sponsor
Kobe University Graduate School of Medicine. Division of Cardiovascular Medicine, Department of Internal Medicine.
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Recruiting
Sex
All
Target Recruitment
60
Inclusion Criteria

Not provided

Exclusion Criteria

1. Pregnant and lactating women 2. Warfarin user

Study & Design

Study Type
Observational
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Angioscopic findings 1. The presence of absence of thrombus attachment 2. Dominant of neointimal coverage grade
Secondary Outcome Measures
NameTimeMethod
Angioscopid findings 1. The color of thrombus (categorized as red, white, and mixed thrombus) 2. Quantitative assessment of thrombus (0-10%, 10-50%, and >50%) 3. Neointima distribution 4. Color and character of vessel wall at stenting site 5. The presence or absence of yellow plaque and quantitative assessment of yellow plaque (0-10%, 10-50%, and >50%) 6. The presence or absence of erosion and dissection Cardiovascular events 1. Cardiac death 2. Cerebral infarction 3. Myocardial infarction 5. Stent thrombosis (Definit or probable based on ARC definition) 6. Revascularization (UTVR, TVT, TLR) Safety 1. Major bleeding (symptomatic intracranial hemorrhage and fatal bleeding) 2. Gastrointestinal and mucosal bleeding 3. Adverse event Pharmacodynamic assessment 1. The relationship between angioscopic findings and platelet aggregation assessed by Verify NOW. 2. The relationship between CYP2C19 polymorphism and drug efficacy
© Copyright 2025. All Rights Reserved by MedPath